Patients’ and clinicians’ attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis
Author(s) -
Matthias Kirschner,
Anastasia Theodoridou,
Paolo FusarPoli,
Stefan Kaiser,
Matthias Jäger
Publication year - 2012
Publication title -
therapeutic advances in psychopharmacology
Language(s) - English
Resource type - Journals
eISSN - 2045-1261
pISSN - 2045-1253
DOI - 10.1177/2045125312464106
Subject(s) - psychosis , psychiatry , medicine , psychology , pediatrics , psychotherapist
The acceptance and use of long-acting depot antipsychotics has been shown to be influenced by the attitudes of patients and clinicians. Depot treatment rates are low across countries and especially patients with first-episode psychosis are rarely treated with depot medication. The aim of this article was to review the literature on patients' and clinicians' attitudes towards long-acting depot antipsychotics in subjects with first-episode psychosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom